Advertisements



Rounds Report: Solid Rallied While FDA Due Diligence To Help Branded Therapeutic Innovators

Rounds Report: Solid Rallied While FDA Due Diligence To Help Branded Therapeutic Innovators.....»»

Category: topSource: seekingalphaMay 17th, 2018

Rounds Report: Omeros Rallied Robustly While Stellar FDA Due Diligence To Help Orphan Disease Innovators

Rounds Report: Omeros Rallied Robustly While Stellar FDA Due Diligence To Help Orphan Disease Innovators.....»»

Category: topSource: seekingalphaMay 16th, 2018

Rounds Report: Omeros Rallied While Stellar FDA Due Diligence To Help Atara Biotherapeutics

Rounds Report: Omeros Rallied While Stellar FDA Due Diligence To Help Atara Biotherapeutics.....»»

Category: topSource: seekingalphaMay 13th, 2018

Rounds Report: Solid Biosciences Garnered Big Profits While Stellar FDA Due Diligence To Help Nektar

Rounds Report: Solid Biosciences Garnered Big Profits While Stellar FDA Due Diligence To Help Nektar.....»»

Category: topSource: seekingalphaMay 13th, 2018

Rounds Report: Solid Biosciences Rallied While Inspire Medical System Witnessed Substantial Insider Purchases

Rounds Report: Solid Biosciences Rallied While Inspire Medical System Witnessed Substantial Insider Purchases.....»»

Category: topSource: seekingalphaMay 11th, 2018

Rounds Report: Crispr Rallied While FDA Developments Could Benefit Gene-Based Innovators

Rounds Report: Crispr Rallied While FDA Developments Could Benefit Gene-Based Innovators.....»»

Category: topSource: seekingalphaApr 20th, 2018

Rounds Report: Geron Rallied While FDA"s New Guidance Created Tailwinds For Individualized Medicine Innovators

Rounds Report: Geron Rallied While FDA"s New Guidance Created Tailwinds For Individualized Medicine Innovators.....»»

Category: topSource: seekingalphaApr 13th, 2018

Rounds Report: Melinta Rallied While The FDA Approved OsteoDetect

Rounds Report: Melinta Rallied While The FDA Approved OsteoDetect.....»»

Category: topSource: seekingalpha3 hr. 18 min. ago

Rounds Report: Crispr Rallied While The FDA Approved Lumivascular

Rounds Report: Crispr Rallied While The FDA Approved Lumivascular.....»»

Category: topSource: seekingalphaMay 25th, 2018

Rounds Report: Eiger Rallied While Sesen Bio Posted The Strong Interim Data For VISTA

Rounds Report: Eiger Rallied While Sesen Bio Posted The Strong Interim Data For VISTA.....»»

Category: topSource: seekingalphaMay 23rd, 2018

Rounds Report: Eiger Moved Northbound While Spectrum Rallied Strongly Due To ADVANCE Trial Results

Rounds Report: Eiger Moved Northbound While Spectrum Rallied Strongly Due To ADVANCE Trial Results.....»»

Category: topSource: seekingalphaMay 18th, 2018

Rounds Report: Global Blood Therapeutics Rallied While Improving FDA Policies To Help Nektar

Rounds Report: Global Blood Therapeutics Rallied While Improving FDA Policies To Help Nektar.....»»

Category: topSource: seekingalphaMay 10th, 2018

Rounds Report: Solid Biosciences Bull Charged Ahead While Portola Gained FDA Approval Of AndexXa

Rounds Report: Solid Biosciences Bull Charged Ahead While Portola Gained FDA Approval Of AndexXa.....»»

Category: topSource: seekingalphaMay 6th, 2018

Rounds Report: Exelixis Rallied Due To Positive Earnings While Achaogen Is Set For A Strong Comeback

Rounds Report: Exelixis Rallied Due To Positive Earnings While Achaogen Is Set For A Strong Comeback.....»»

Category: topSource: seekingalphaMay 4th, 2018

Rounds Report: Nephros Rallied While The Eleven Train Continued To Head Further North

Rounds Report: Nephros Rallied While The Eleven Train Continued To Head Further North.....»»

Category: topSource: seekingalphaMay 3rd, 2018

Rounds Report: Solid Continued Its Comeback And An Improved FDA Policy To Help Nektar

Rounds Report: Solid Continued Its Comeback And An Improved FDA Policy To Help Nektar.....»»

Category: topSource: seekingalphaApr 26th, 2018

Rounds Report: Eleven Train Took Off While Improved FDA Policy Favors Infectious Disease Innovators

Rounds Report: Eleven Train Took Off While Improved FDA Policy Favors Infectious Disease Innovators.....»»

Category: topSource: seekingalphaApr 24th, 2018

Rounds Report: Solid Biosciences Is Making A Comeback While Improving FDA Policies To Favor Nektar

Rounds Report: Solid Biosciences Is Making A Comeback While Improving FDA Policies To Favor Nektar.....»»

Category: topSource: seekingalphaApr 22nd, 2018

Rounds Report: Sangamo Rallied While The Fundamentals Of Ultragenyx And Intercept Improved

Rounds Report: Sangamo Rallied While The Fundamentals Of Ultragenyx And Intercept Improved.....»»

Category: topSource: seekingalphaApr 18th, 2018

Public Service Enterprise to Gain from Capital Investments

Public Service Enterprise (PEG) continues to gain from solid regulated and non-regulated portfolio. On May 23, we issued an updated research report on Public Service Enterpris.....»»

Category: smallbizSource: nytMay 25th, 2018

MCX rallies 8% on merger talks with NSE

The stock rallied 8% to Rs 775 after the media report suggested that the company has entered into merger talks with the NSE ahead of the implementation of the universal exchange framework in October......»»

Category: topSource: business-standardMay 25th, 2018